Xenotransplantation: Immune barriers beyond hyperacute rejection

Clinical Science

Volumn 93, Issue 6, 1997, Pages 493-505

  Dorling, Anthony ^a   Lechler, Robert I ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

T cell xenoresponse; Xenograft accommodation; Xenotransplantation

Indexed keywords

ANTIBODY; CD4 ANTIGEN; INTERLEUKIN 2;

ANIMAL CELL; CELL ACTIVATION; CELL CLONE; CELL PROLIFERATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENETIC TRANSFECTION; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; SWINE; T LYMPHOCYTE; TRANSGENIC ANIMAL; XENOTRANSPLANTATION; ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL LINE; CELLULAR IMMUNITY; IMMUNOLOGY; VASCULAR ENDOTHELIUM; XENOGRAFT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELL LINE; ENDOTHELIUM, VASCULAR; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; IMMUNOSUPPRESSION; MODELS, IMMUNOLOGICAL; SWINE; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS;

EID: 0030712911     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0930493     Document Type: Review

References (39)

1. Calne RY. Organ transplantation between widely disparate species. Transplant Proc 1970; 11: 550-3.
2. Cozzi E, White DJG. The generation of transgenic pigs as potential organ donors for humans. Nature Med 1995; 1: 964-6.
3. Dorling A, Lechler RI. Prospects for xenografting. Curr Opin Immunol 1994; 6: 765-9.
4. Advisory Group on the Ethics of Xenotransplantation. Animal tissue into humans. London: Stationery Office, 1997.
5. Dorling A, Riesbeck K, Warrens A, Lechler R. Clinical xenotransplantation of solid organs. Lancet 1997; 349: 867-71.
6. Bach FH, Winkler H, Ferran C, Hancock WW, Robson SC. Delayed xenograft rejection. Immunol Today 1996; 17: 379-84.
7. Fischel RJ, Platt JL, Matas AJ, et al. Prolonged survival of a discordant cardiac xenograft in a rhesus monkey. Transplant Proc 1991; 23: 589-90.
8. Platt JL, Vercellotti GM, Dalmasso AP, et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 1990; 11: 450-6.
9. Alexandre GPJ, Latinne D, Gianello P, Squiffet JP. Pre-formed cytotoxic antibodies and ABO-incompatible grafts. Clin Transplant 1991; 5: 583-94.
10. Ross CN, Gaskin G, Gregor-Macgregor S, et al. Renal transplantation following immunoadsorption in highly sensitized recipients. Transplantation 1993; 55: 785-9.
11. Winkler H, Ferran C, Bach FH. Accommodation of xenografts: a concept revisited (Review). Xenotransplantation 1995; 2: 53-7.
12. Balla G, Jacob HS, Balla J, et al. Ferritin: a cytoprotective antioxidant stratagem of endothelium. J Biol Chem 1992; 267: 18148-53.
13. Magee JC, Platt JL. Xenograft rejection - molecular mechanisms and therapeutic implications. Ther Immunol 1994; 1: 45-58.
14. Hasan R, Van den Bogaerde J, Forty J, Wright L, Wallwork J, White DJG. Xenograft adaptation is dependent on the presence of antispecies antibody, not prolonged residence in the recipient. Transplant Proc 1992; 24: 531-2.
15. Bach FH, Turman MA, Vercellotti GM, Platt JL, Dalmasso AP. Accommodation: a working paradigm for progressing toward clinical discordant xenografting. Transplant Proc 1991; 23: 205-7.
16. Dorling A, Stocker C, Tsao T, Haskard DO, Lechler RI. In vitro accommodation of immortalized porcine endothelial cells: resistance to complement mediated lysis and down-regulation of VCAM expression induced by low concentrations of polyclonal human IgG antipig antibodies. Transplantation 1996; 62: 1127-36.
17. Jat PS, Sharp PA. Large T antigens of simian virus 40 and polyomavirus efficiently establish primary fibroblasts. J Virol 1986; 59: 746-50.
18. Galili U. Interaction of the natural anti-gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 1993; 14: 480-2.
19. Dorling A, Lechler RI. The passenger leukocyte, dendritic cell and antigen-presenting cells (APC). In: Tilney NL, Strom TB, Paul LC, eds. Transplantation biology; cellular and molecular aspects. Philadelphia: Lippincott-Raven, 1996: 355-79.
20. Lechler RI, Batchelor JR. Immunogenicity of retransplanted rat kidney allografts. J Exp Med 1982; 156: 1835-41.
21. Wecker H, Auchincloss H. Cellular mechanisms of rejection. Curr Opin Immunol 1992; 4: 561-6.
22. van Oers MHJ, Pinkster J, Zeijlemaker WP. Quantification of antigen-reactive cells among human T lymphocytes. Eur J Immunol 1978; 8: 477.
23. Lechler RI, Lombardi G, Batchelor JR, Reinsmoen N, Bach FH. The molecular basis of alloreactivity. Immunol Today 1990; 11: 83-8.
24. Egner W, Andreesen R, Hart DN. Allostimulatory cells in fresh human blood: heterogeneity in antigen-presenting cell populations. Transplantation 1993; 56: 945-50.
25. Liu Z, Sun YK, Xi YP, et al. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med 1993; 177: 1643-50.
26. Dorling A, Riesbeck K, Lechler RI. The T cell response to xenografts. Xeno 1996; 4: 68-76.
27. Dorling A, Lombardi G, Binns R, Lechler RI. Detection of primary direct and indirect human anti-porcine T cell responses using a porcine dendritic cell population. Eur J Immunol 1996; 26: 1378-87.
28. Dorling A, Binns R, Lechler RI. Cellular xenoresponses: although vigorous, direct human T cell anti-pig primary xenoresponses are significantly weaker than equivalent alloresponses. Xenotransplantation 1996; 3: 149-57.
29. Dorling A, Binns R, Lechler RI. Direct human T-cell anti-pig xenoresponses are vigorous but significantly weaker than direct alloresponses. Transplant Proc 1996; 28: 653.
30. Mueller JP, Evans MJ, Cofiell R, Rother RP, Matis LA, Elliot EA. Porcine vascular cell adhesion molecule (VCAM) mediates endothelial cell adhesion to human T cells. Development of blocking antibodies specific for porcine VCAM. Transplantation 1995; 60: 1299-306.
31. Maher SE, Karmann K, Min W, Hughes CC, Pober JS, Bothwell AL. Porcine endothelial CD86 is a major costimulator of xenogeneic human T cells: cloning, sequencing, and functional expression in human endothelial cells. J Immunol 1996; 157: 3838-44.
32. Gustafsson K, Germana S, Hirsch F, Pratt K, LeGuern C, Sachs DH. Structure of miniature swine class II DRB genes; conservation of hypervariable amino acid residues between distantly related mammalian species. Proc Natl Acad Sci USA 1990; 87: 9798-802.
33. Dorling A, Binns R, Lechler RI. Significant primary indirect human T-cell anti-pig xenoresponses observed using immature porcine dendritic cells and SLA-class II-negative endothelial cells. Transplant Proc 1996; 28: 654.
34. Dorling A, Binns R, Lechler RI. Cellular xenoresponses: observation of significant primary indirect human T cell anti-pig xenoresponses using co-stimulator-deficient or SLA class II-negative porcine stimulators. Xenotransplantation 1996; 3: 112-19.
35. Rock KL, Benacerraf BJ, Abbas AK. Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J Exp Med 1984; 160: 1102-13.
36. Liu LM, MacPherson GG. Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime T cells. J Exp Med 1993; 177: 1299-307.
37. Bach FH, Ferran C, Hechenleitner P, et al. Accommodation of vascularized xenografts: expression of 'protective genes' by donor endothelial cells in a host Th2 cytokine environment. Nature Med 1997; 3: 196-204.
38. Murray AG, Khodadoust MM, Pober JS, Bothwell ALM. Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD26. Immunity 1994; 1: 57-63.
39. Yamada K, Sachs DH, DerSimonian H. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways. J Immunol 1995; 155: 5249-56.